Cancer Imaging Systems Market Size To Be Worth USD 12.24 Billion by 2027 Growing at a CAGR of 5.3%, says Emegen Research

The global cancer imaging systems market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

The rapid growth of the market is caused by growing technological advancements and increased investments in cancer imaging. Hologic, Inc. received approval for its 3DQuorum^TM Imaging Technology, driven by Genius AI^TM, from the U.S. Food and Drug Administration (FDA) in November 2019. The technology works with Hologic’s Clarity HD^TM high-resolution imaging technology at the same time and helps radiologists reduce the volume of tomosynthesis images by 66.0%. Because of such developments, the breast imaging system would generate higher-resolution 3D images, better workflow, and an improved mammography experience for patents requiring low radiation dose.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/222

Key Highlights From The Report

• Agilent Technologies Inc. made an announcement in July 2019 about the signing of an agreement to acquire of BioTek Instruments, a private firm with USD 1.17 billion. BioTek is involved in the design, manufacture and distribution, including cell imaging systems, of ground-breaking life science instrumentation.
• MRI offers the advantage of imaging parts of soft body tissue that are occasionally difficult to examine using other types of modalities. The identification and location of some cancers are carried out with superior accuracy with MRI. In addition, the most appropriate brain and spinal cord tumour imaging technique is an MRI that deploys contrast dye.
• Lung cancer is a prevalent type of cancer in men and the third leading type of cancer in women, with 2 million new cases being registered in 2018. The top three countries with the highest disease rate in 2018 were Hungary, Serbia, and France.
• Diagnostics centres are projected to grow in the forecast period at the fastest CAGR of 10 percent. In order to assist in the detection of diseases in people with specific symptoms, diagnostic centres are equipped with the required imaging system and specialist staff.
• Due to the high adoption of advanced imaging technologies, increasing incidences of cancer, established healthcare infrastructure, and the undertaking of various initiatives to raise awareness about the disease, the market in the North American region held the largest market share in 2019.
• Key participants include GE Healthcare, Becton, Dickinson, and Company, Hitachi Medical, Thermo Fisher Scientific Inc., Agilent Technologies, CR Bard Inc., Abbott, Roche, Illumina Inc., and Philips Healthcare, among others.

Buy Your Copy Now (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/222

Emergen Research has segmented the global cancer imaging systems market on the basis of imaging systems, application, end-user, and region:

Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)

• Mammography
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Positron Emission Tomography (PET)
• Others

Application Outlook (Revenue, USD Billion; 2017-2027)

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Melanoma
• Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

• Hospitals & Clinics
• Diagnostic Centers
• Others

Click on the link to read key highlights of the report and look at projected trends for years to come: https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

Regional Outlook (Revenue, USD Billion; 2017-2027)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. U.K.
  3. France
  4. BENELUX
  5. Rest of Europe
• Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• Middle East & Africa
  1. Saudi Arabia
  2. U.A.E.
  3. Rest of MEA

Reasons to buy the report:

1. This study segments the Cancer Imaging Systems market and derives the precise valuation of the overall, as well as segment-based, market across different industry verticals, geographies, and products.
2. The report will help participants understand the trajectory of the progress of the market and provide information on key drivers, restraints, challenges, threats, and opportunities for the growth of the Cancer Imaging Systems sectors.
3. This Cancer Imaging Systems report would allow readers to be well-versed with the existing competition and gain more insights to improve their standing in the worldwide business. The competitive landscape considers the dominant competitors, along with product launches and technological advancements, strategic expansions, mergers and acquisitions, and procurement strategies implemented by key players in the Cancer Imaging Systems market.

Key features of the report:

• To study the key aspects impacting the Cancer Imaging Systems market size.
• To identify growth prospects in the Cancer Imaging Systems market.
• To analyze the Cancer Imaging Systems market segments and deduce the dominant trends observed in the industry.
• To examine the Cancer Imaging Systems market by investigating the available products, market share, and value proposition of the products.
• To analyze the industry by assessing the scope and application of the Cancer Imaging Systems market and highlight the growth of each application.

Table of Content

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2020-2030

Chapter 3. Key Insights

Chapter 4. Cancer Imaging Systems Market Segmentation & Impact Analysis

4.1. Cancer Imaging Systems Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Market indicators analysis

4.2.2. Market drivers’ analysis

4.2.3. Market restraints analysis

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Continued…

Explore Complete Table of Content@ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

Insights into our Other Published Healthcare Reports:

Bioremediation Market Projected To Be Worth USD 334.70 Billion By 2027 Growing at a CAGR of 15.5% | Emergen Research

Cancer Imaging Systems Market To Reach USD 12.24 Billion by 2027 | Emergen Research

Intelligent Drug Discovery Market Size To Be Worth USD 3,711.8 Million by 2027 | Emergen Research

AI-Enabled Medical Imaging Solutions Market Size To Be Worth USD 4,720.6 Million by 2027 | Emergen Research

Prenatal Testing and Newborn Screening Market Size To Be Worth USD 10.85 Billion by 2027 | Emergen Research

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-cancer-imaging-systems-market